Cargando…

The MRZ reaction in primary progressive multiple sclerosis

BACKGROUND: The MRZ reaction (MRZR), composed of the three antibody indices (AI) against measles, rubella and varicella zoster virus and found positive in the majority of relapsing-remitting multiple sclerosis (RRMS) patients, is absent in other inflammatory neurological diseases (OIND). So far, it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hottenrott, Tilman, Dersch, Rick, Berger, Benjamin, Rauer, Sebastian, Huzly, Daniela, Stich, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294835/ https://www.ncbi.nlm.nih.gov/pubmed/28166789 http://dx.doi.org/10.1186/s12987-016-0049-7

Ejemplares similares

The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis
por: Hottenrott, Tilman, et al.
Publicado: (2018)

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
por: Robinson, Tilman, et al.
Publicado: (2020)

The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort
por: Hottenrott, Tilman, et al.
Publicado: (2015)

The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral Involvement
por: Venhoff, Nils, et al.
Publicado: (2019)

Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
por: Berger, Benjamin, et al.
Publicado: (2015)

Screening for onconeural antibodies in neuromyelitis optica spectrum disorders
por: Berger, Benjamin, et al.
Publicado: (2017)

Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction
por: Vlad, Benjamin, et al.
Publicado: (2023)

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis
por: Vlad, Benjamin, et al.
Publicado: (2023)

Do patients with schizophreniform and bipolar disorders show an intrathecal, polyspecific, antiviral immune response? A pilot study
por: Endres, Dominique, et al.
Publicado: (2017)

Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis in children: a systematic review
por: Dersch, Rick, et al.
Publicado: (2016)

The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis
por: Dersch, R, et al.
Publicado: (2015)

Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients
por: Endres, Dominique, et al.
Publicado: (2015)

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
por: Abdelhak, Ahmed, et al.
Publicado: (2019)

Primary Epstein-Barr virus infection with polyradiculitis: a case report
por: Hottenrott, Tilmann, et al.
Publicado: (2013)

Alterations in Cerebrospinal Fluid in Patients with Bipolar Syndromes
por: Endres, Dominique, et al.
Publicado: (2016)

Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies
por: Endres, Dominique, et al.
Publicado: (2020)

Erythrophages do not develop when lumbar CSF and blood samples are mixed in vitro
por: Dersch, R., et al.
Publicado: (2018)

Parvovirus B19 and mumps virus antibodies are major constituents of the intrathecal immune response in European patients with MS and increase the diagnostic sensitivity and discriminatory power of the MRZ reaction
por: Jarius, S., et al.
Publicado: (2021)

Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review
por: Ziemssen, T., et al.
Publicado: (2015)

Efficacy and safety of pharmacological treatments for neuroborreliosis—protocol for a systematic review
por: Dersch, Rick, et al.
Publicado: (2014)

Lymphocytes subset composition and modulation of sphingosie-1-phosphate mediated migration in multiple sclerosis patients treated with fingolimod or interferon-β
por: Sic, Heiko, et al.
Publicado: (2012)

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

Symptomatic Therapy and Rehabilitation in Primary Progressive Multiple Sclerosis
por: Khan, Fary, et al.
Publicado: (2011)

Perception of stigma in patients with primary progressive multiple sclerosis
por: Pérez-Miralles, Francisco, et al.
Publicado: (2019)

The Role of B Cells in Primary Progressive Multiple Sclerosis
por: Holloman, Jameson P., et al.
Publicado: (2021)

Guidelines for diagnosis and treatment in neurology – Lyme neuroborreliosis
por: Rauer, Sebastian, et al.
Publicado: (2020)

Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis
por: Jia, Xiaoming, et al.
Publicado: (2018)

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis
por: Hauser, Stephen L., et al.
Publicado: (2021)

Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic
por: Wong, Jamie K, et al.
Publicado: (2023)

Anti-Thyroid Peroxidase and Anti-Thyroglobulin Autoantibodies in the Cerebrospinal Fluid of Patients with Unipolar Depression
por: Dersch, Rick, et al.
Publicado: (2020)

Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring
por: Stoessel, Daniel, et al.
Publicado: (2018)

Multifaceted Analysis of Cerebrospinal Fluid and Serum from Progressive Multiple Sclerosis Patients: Potential Role of Vitamin C and Metal Ion Imbalance in the Divergence of Primary Progressive Multiple Sclerosis and Secondary Progressive Multiple Sclerosis
por: Pomary, Precious Kwadzo, et al.
Publicado: (2023)

Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis
por: Rossi, Silvia, et al.
Publicado: (2013)

Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis
por: Piancone, Federica, et al.
Publicado: (2018)

Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis
por: Daniels, K., et al.
Publicado: (2020)

Magnetic Resonance Imaging in Primary Progressive Multiple Sclerosis Patients: Review
por: Siger, Malgorzata
Publicado: (2022)

Vitamin D Deficiency in Adult Patients with Schizophreniform and Autism Spectrum Syndromes: A One-Year Cohort Study at a German Tertiary Care Hospital
por: Endres, Dominique, et al.
Publicado: (2016)

Measuring Treatment Response in Progressive Multiple Sclerosis—Considerations for Adapting to an Era of Multiple Treatment Options
por: Krajnc, Nik, et al.
Publicado: (2021)

Methodological quality of guidelines for management of Lyme neuroborreliosis
por: Dersch, R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tgdpu0jnm63kdo22jcladkqdvp